Cardio Diagnostics Holdings, Inc. - CDIO Company Short-Term Debt

cardiodiagnosticsinc.com (CDIO) - corporate logo

The visual price representation available on the page confirms the resilience of Cardio Diagnostics (CDIO), whose business relies on a US retail model that minimizes external political threats. The environmental development vector is implemented through AI diagnostics, which reduce the amount of medical waste. Biotechnology security is guaranteed by internal control over DNA algorithms while outsourcing logistics. The current separate_debt_short figure is 0.00.

CDIO (Cardio Diagnostics) Company Short-Term Debts history from 04/28/2023 to 10/28/2026

Cardio Diagnostics Holdings Inc. - analytical breakdowns and key metrics (CDIO)

- price and consensus price forecast:
Stock Price Cardio Diagnostics Holdings, Inc.|CDIO - Analyst Consensus Forecast
- market capitalization data:
Market Value Cardio Diagnostics Holdings|CDIO - Business Value
- book capitalization data:
Book Value per Share Cardio Diagnostics|CDIO - Book Capitalization|Market Value to Book Value Ratio cardiodiagnosticsinc.com|CDIO - Aggregate Company Assets
- debt and liquidity data:
Total Debt to Equity Ratio Cardio Diagnostics|CDIO - Long-Term Liabilities to Capital|Short-Term Debt to Equity Cardio Diagnostics Holdings, Inc.|CDIO - Company Total Debt Obligations|Debts to Book Capitalization Cardio Diagnostics Holdings|CDIO - Long-Term Debt Volume|Company Short-Term Debt Cardio Diagnostics
Analysis of all company metrics:cardiodiagnosticsinc.com CDIO
Finished products of Cardio Diagnostics Holdings, Inc.

The implementation of AI diagnostics and genetic testing requires significant capital expenditures from Cardio Diagnostics (CDIO) to scale personalized medicine. By analyzing the volume of short-term debt, an investor assesses obligations with maturities of up to one year, where a sharp increase in credit load signals a risk of a liquidity gap and reduces the overall stability of the business's financial model.

Competitor analysis for Cardio Diagnostics

Agilent - Company Short-Term Debts|DGX: Company Short-Term Debts|Company Short-Term Debt Illumina Corp|Exact Sciences Inc. (EXAS) - Company Short-Term Indebtedness|RVTY (Revvity, Inc.) - Company Short-Term Debts|Company Short-Term Debts BIO|Company Short-Term Debt Anbio (NNNN)|Company Short-Term Debt Sotera Health Corp SHC|QDEL: Company Current Liabilities|OPKO Health Corp. - Short-Term Debt|Company Short-Term Debt CDNA (CareDx, Inc.)|MRVI - Short-Term Debt Volume|Fulgent Genetics - Company Short-Term Debts|LAB (Standard BioTools Inc) - Short-Term Debt Volume|CTKB: Company Short-Term Debt|Short-Term Debt Volume OraSure Corp|Company Short-Term Debts XGN (Exagen Inc.)|Company Current Liabilities mdxhealth.com (MDXH)|Company Short-Term Debts LUCD (Lucid Diagnostics)|Prenetics Global Limited - Company Short-Term Debts|Company Short-Term Debt Insight Molecular (IMDX)|TRIB - Company Short-Term Loans and Borrowings|Company Short-Term Debts ProPhase Labs, Inc.|ainos.com (AIMD) - Company Short-Term Indebtedness|CODX: Company Short-Term Debts|Short-Term Debt Volume HSCS|Biomerica, Inc - Company Short-Term Debt|Short-Term Debt Virax Biolabs Corp VRAX|Company Current Liabilities Bluejay Diagnostics|Company Short-Term Loans and Borrowings aspirawh.com AWH|Accelerate Diagnostics, Inc. (AXDX) - Company Short-Term Debts|CNTG - Company Short-Term Indebtedness|enzo.com - Company Short-Term Debts|Fresh2 Group (FRES) - Short-Term Debt Volume|GENE (Genetic Technologies Ltd) - Company Short-Term Debts|Company Short-Term Debts 23andme.com|PMD: Company Short-Term Debts